carvedilol has been researched along with nad in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Habon, T; Halmosi, R; Kesmarky, G; Past, T; Sumegi, B; Szabados, E; Toth, K | 1 |
Dziewulska, J; Jesko, H; Strosznajder, RP | 1 |
3 other study(ies) available for carvedilol and nad
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The effect of carvedilol on enhanced ADP-ribosylation and red blood cell membrane damage caused by free radicals.
Topics: Adenosine Diphosphate Ribose; ADP Ribose Transferases; Adrenergic Antagonists; Animals; Blood Viscosity; Carbazoles; Carvedilol; Erythrocyte Membrane; Hemorheology; Humans; Lipid Peroxidation; Male; Myocardial Reperfusion Injury; NAD; Perfusion; Poly(ADP-ribose) Polymerases; Propanolamines; Rats; Rats, Wistar; Reactive Oxygen Species; Signal Transduction | 2001 |
Effect of carvedilol on neuronal survival and poly(ADP-ribose) polymerase activity in hippocampus after transient forebrain ischemia.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Animals; Carbazoles; Carvedilol; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Gerbillinae; Hippocampus; Ischemic Attack, Transient; Male; NAD; Neurons; Poly(ADP-ribose) Polymerases; Propanolamines; Reperfusion Injury; Time Factors | 2005 |